About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Open-label Adjunctive Zonisamide for Bipolar Disorder

NCT00047567·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Elan Pharmaceuticals

Age

6–17

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Bipolar I/II
Average intelligence
Taking at least one, but no more than two mood stabilizers

The record

StatusTerminated

PhasePhase 4

Taking part20

StartedJul 2002

UpdatedDec 14, 2015

Conditions

Bipolar Disorders

Clareo Health | Open-label Adjunctive Zonisamide for Bipolar Disorder